Page 26 - pdf_publisher2_project

№ 4. 2012 г. Журнал «Паллиативная медицина и реабилитация»

26

ческих местно-регионарных рецедивов РМЖ. //Вопр. онкол.– 2009.– т. 55, № 4. – С. З87-391.

4. Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2008 г. – М., 2009.– 202 с.

5. Щепотин И.Б., Зотов А.С., Костюченко Е.А. Роль пролак тина в физиологии и патологии молочной железы. //Вопр. онкол.– 2007. – т. 53, № 2. – С. 131-139.

6. Ganchevska Pepa G., Uchikov Angel P., Ishev Vasilii S. et al. Estrogen receptors – known and unknown biological functions. //Folia med.– 2006.– v. 48, № 2. – P. 5-10.

7. Marx Jeah. All in the stroma: Cancer Cosa Nostra. //Science.– 2008. – v. 320, № 5872.– P. 38-41.

8. Miettinen Minna, Isomao Veli, Peltoketo Hellevi et. al. Estrogen metabolism as a regulator of estrogen in the mammary gland. //J. Mammary gland. Biol. and Neoplasia. – 2000.– v. 5, № 3.– P. 259 – 270.

9. Miller W. R. Estrogen and breast cancer. – USA, 1996/ – 207 p.

10. Voogd A. C., van Oost F. J., Rutgers E.S. et al. Long – term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. // Eur. J. Cancer. – 2005. – v. 41, № 17. – P. 2637-2644.

11. Wiebe J. P., Levis M. J., Cialucu V. et al. The role of progesterone metabolites in breast cancer. //Steroid Biochem. and Mol. Biol. – 2005. – v. 93, № 2 – 5. – P. 201 – 208. 12. Yager J. D., Davidson N. E. Estrogen carcenogenesis in breast cancer. //New Engl. J. Med. – 2006. – v. 354. – P. 270 – 282.

13. Zheng Ze – Yi, Bay Boon – Huat, Aw Swee – Eng, Lin Valerie C. – L. A novel antiestrogenic mechanism in progesterone receptor – transfected breast cancer cells. //J. Biol. Chem. – 2005. – v. 280, № 17. – P. 17480 – 17487.

Поступила 30.05.2012 s